Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > EPPK1(Gene name) > Human
  • Add your favorite
  • EPPK1 (Gene name),
  • Epiplakin (Protein name ),  EPIPL_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    EPPK1(EPIPL);
    Protein name:
    Epiplakin;
    Alternative:
    450 kDa epidermal antigen;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    N/A
    Function:
    N/A
    Subcellular Location:
    Cytoplasm cytoskeleton
    Protein Attributes:
    Sequence length:
    5090
    Sequence:
    50:
    MSGHTLPPLP | VPGTNSTEQA | SVPRAMAATL | GAGTPPRPQA | RSIAGVYVEA | 
    100:
    SGQAQSVYAA | MEQGLLPAGL | GQALLEAQAA | TGGLVDLARG | QLLPVSKALQ | 
    150:
    QGLVGLELKE | KLLAAERATT | GYPDPYGGEK | LALFQAIGKE | VVDRALGQSW | 
    200:
    LEVQLATGGL | VDPAQGVLVA | PEPACHQGLL | DRETWHKLSE | LEPGTGDLRF | 
    250:
    LNPNTLERLT | YHQLLERCVR | APGSGLALLP | LKITFRSMGG | AVSAAELLEV | 
    300:
    GILDEQAVQG | LREGRLAAVD | VSARAEVRRY | LEGTGSVAGV | VLLPEGHKKS | 
    350:
    FFQAATEHLL | PMGTALPLLE | AQAATHTLVD | PITGQRLWVD | EAVRAGLVSP | 
    400:
    ELHEQLLVAE | QAVTGHHDPF | SGSQIPLFQA | MKKGLVDRPL | ALRLLDAQLA | 
    450:
    TGGLVCPARR | LRLPLEAALR | CGCLDEDTQR | QLSQAGSFSD | GTHGGLRYEQ | 
    500:
    LLALCVTDPE | TGLAFLPLSG | GPRGGEPQGP | PFIKYSTRQA | LSTATATVSV | 
    550:
    GKFRGRPVSL | WELLFSEAIS | SEQRAMLAQQ | YQEGTLSVEK | LAAELSATLE | 
    600:
    QAAATARVTF | SGLRDTVTPG | ELLKAEIIDQ | DLYERLEHGQ | ATAKDVGSLA | 
    650:
    SAQRYLQGTG | CIAGLLLPGS | QERLSIYEAR | CKGLLRPGTA | LILLEAQAAT | 
    700:
    GFIIDPKANK | GHSVEEALRA | AVIGPDVFAK | LLSAERAVTG | YTDPYTGQQI | 
    750:
    SLFQAMQKGL | IVREHGIRLL | EAQIATGGVI | DPVHSHRVPV | DVAYRRGYFD | 
    800:
    QMLNLILLDP | SDDTKGFFDP | NTHENLTYLQ | LLERCVRDPE | TGLYLLPLSS | 
    850:
    TQSPLVDSAT | QQAFQNLLLS | VKYGRFQGQR | VSAWELINSE | YFSEGRRRQL | 
    900:
    LRRYRQREVT | LGQVAKLLEA | ETQRQADIML | PALRSRVTVH | QLLEAGIIDQ | 
    950:
    QLLDQVLAGT | ISPEALLLMD | GVRRYLCGLG | AVGGVRLLPS | GQRLSLYQAM | 
    1000:
    RQKLLGPRVA | LALLEAQAAT | GTIMDPHSPE | SLSVDEAVRR | GVVGPELYGR | 
    1050:
    LKRAEGAIAG | FRDPFSGKQV | SVFQAMKKGL | IPWEQAARLL | EAQVATGGII | 
    1100:
    DPTSHHHLPM | PVAIQRGYVD | QEMETALSSS | SETFPTPDGQ | GRTSYAQLLE | 
    1150:
    ECPRDETSGL | HLLPLPESAP | ALPTEEQVQR | SLQAVPGAKD | GTSLWDLLSS | 
    1200:
    CHFTEEQRRG | LLEDVQEGRT | TVPQLLASVQ | RWVQETKLLA | QARVMVPGPR | 
    1250:
    GEVPAVWLLD | AGIITQETLE | ALAQGTQSPA | QVAEQPAVKA | CLWGTGCVAG | 
    1300:
    VLLQPSGAKA | SIAQAVRDGL | LPTGLGQRLL | EAQVASGFLV | DPLNNQRLSV | 
    1350:
    EDAVKVGLVG | RELSEQLGQA | ERAAAGYPDP | YSRASLSLWQ | AMEKGLVPQN | 
    1400:
    EGLPLLQVQL | ATGGVVDPVH | GVHLPQAAAC | RLGLLDTQTS | QVLTAVDKDN | 
    1450:
    KFFFDPSARD | QVTYQQLRER | CVCDSETGLL | LLPLPSDTVL | EVDDHTAVAL | 
    1500:
    RAMKVPVSTG | RFKGCSVSLW | DLLLSEYVGA | DKRRELVALC | RSGRAAALRQ | 
    1550:
    VVSAVTALVE | AAERQPLQAT | FRGLRKQVSA | RDLFRAQLIS | RKTLDELSQG | 
    1600:
    TTTVKEVAEM | DSVKRSLEGG | NFIAGVLIQG | TQERMSIPEA | LRRHILRPGT | 
    1650:
    ALVLLEAQAA | TGFIIDPAEN | RKLTVEEAFK | AGMFGKETYV | KLLSAERAVT | 
    1700:
    GYTDPYTGQQ | ISLFQAMQKD | LIVREHGIRL | LEAQIATGGI | IDPVHSHRVP | 
    1750:
    VDVAYRCGYF | DEEMNRILAD | PSDDTKGFFD | PNTHENLTYL | QLLERCVEDP | 
    1800:
    ETGLYLLQII | KKGENYVYIN | EATRHVLQSR | TAKMRVGRFA | DQVVSFWDLL | 
    1850:
    SSPYFTEDRK | RELIQEYGAQ | SGGLEKLLEI | ITTTIEETET | QNQGIKVAAI | 
    1900:
    RGEVTAADLF | NSRVIDQKTL | HTLRVGRTGG | QALSTLECVK | PYLEGSDCIA | 
    1950:
    GVTVPSTREV | MSLHEASRKE | LIPAAFATWL | LEAQAATGFL | LDPCTRQKLS | 
    2000:
    VDEAVDVGLV | NEELRERLLK | AERAATGYRD | PATGDTIPLF | QAMQKQLIEK | 
    2050:
    AEALRLLEVQ | VATGGVIDPQ | HHHRLPLETA | YRRGCLHKDI | YALISDQKHM | 
    2100:
    RKRFVDPNTQ | EKVSYRELQE | RCRPQEDTGW | VLFPVNKAAR | DSEHIDDETR | 
    2150:
    RALEAEQVEI | TVGRFRGQKP | TLWALLNSEY | VTEEKKLQLV | RMYRTHTRRA | 
    2200:
    LQTVAQLILE | LIEKQETSNK | HLWFQGIRRQ | ITASELLSSA | IITEEMLQDL | 
    2250:
    ETGRSTTQEL | MEDDRVKRYL | EGTSCIAGVL | VPAKDQPGRQ | EKMSIYQAMW | 
    2300:
    KGVLRPGTAL | VLLEAQAATG | FVIDPVRNLR | LSVEEPVPAG | VVGSEIQEKL | 
    2350:
    LSAERAVTGY | TDPYTGQQIS | LFQAMQKDLI | VREHGIRLLE | AQIATGGVID | 
    2400:
    PVHSHRVPVD | VAYRRGYFDE | EMNRVLADPS | DDTKGFFDPN | THENLTYVQL | 
    2450:
    LRRCVPDPDT | GLYMLQLAGR | GSAVHQLSEE | LRCALRDARV | TPGSGALQGQ | 
    2500:
    SVSVWELLFY | REVSEDRRQD | LLSRYRAGTL | TVEELGATLT | SLLAQAQAQA | 
    2550:
    RAEAEAGSPR | PDPREALRAA | TMEVKVGRLR | GRAVPVWDVL | ASGYVSRAAR | 
    2600:
    EELLAEFGSG | TLDLPALTRR | LTAIIEEAEE | APGARPQLQD | ARRGPREPGP | 
    2650:
    AGRGDGDSGR | SQREGQGEGE | TQEAAAAAAA | ARRQEQTLRD | ATMEVQRGQF | 
    2700:
    QGRPVSVWDV | LFSSYLSEAR | RDELLAQHAA | GALGLPDLVA | VLTRVIEETE | 
    2750:
    ERLSKVSFRG | LRRQVSASEL | HTSGILGPET | LRDLAQGTKT | LQEVTEMDSV | 
    2800:
    KRYLEGTSCI | AGVLVPAKDQ | PGRQEKMSIY | QAMWKGVLRP | GTALVLLEAQ | 
    2850:
    AATGFVIDPV | RNLRLSVEEA | VAAGVVGGEI | QEKLLSAERA | VTGYTDPYTG | 
    2900:
    QQISLFQAMQ | KDLIVREHGI | RLLEAQIATG | GVIDPVHSHR | VPVDVAYRRG | 
    2950:
    YFDEEMNRVL | ADPSDDTKGF | FDPNTHENLT | YVQLLRRCVP | DPDTGLYMLQ | 
    3000:
    LAGRGSAVHQ | LSEELRCALR | DARVTPGSGA | LQGQSVSVWE | LLFYREVSED | 
    3050:
    RRQDLLSRYR | AGTLTVEELG | ATLTSLLAQA | QAQARAEAEA | GSPRPDPREA | 
    3100:
    LRAATMEVKV | GRLRGRAVPV | WDVLASGYVS | GAAREELLAE | FGSGTLDLPA | 
    3150:
    LTRRLTAIIE | EAEEAPGARP | QLQDAWRGPR | EPGPAGRGDG | DSGRSQREGQ | 
    3200:
    GEGETQEAAA | AAAAARRQEQ | TLRDATMEVQ | RGQFQGRPVS | VWDVLFSSYL | 
    3250:
    SEARRDELLA | QHAAGALGLP | DLVAVLTRVI | EETEERLSKV | SFRGLRRQVS | 
    3300:
    ASELHTSGIL | GPETLRDLAQ | GTKTLQEVTE | MDSVKRYLEG | TSCIAGVLVP | 
    3350:
    AKDQPGRQEK | MSIYQAMWKG | VLRPGTALVL | LEAQAATGFV | IDPVRNLRLS | 
    3400:
    VEEAVAAGVV | GGEIQEKLLS | AERAVTGYTD | PYTGQQISLF | QAMQKDLIVR | 
    3450:
    EHGIRLLEAQ | IATGGVIDPV | HSHRVPVDVA | YRRGYFDEEM | NRVLADPSDD | 
    3500:
    TKGFFDPNTH | ENLTYVQLLR | RCVPDPDTGL | YMLQLAGRGS | AVHQLSEELR | 
    3550:
    CALRDARVTP | GSGALQGQSV | SVWELLFYRE | VSEDRRQDLL | SRYRAGTLTV | 
    3600:
    EELGATLTSL | LAQAQAQARA | EAEAGSPRPD | PREALRAATM | EVKVGRLRGR | 
    3650:
    AVPVWDVLAS | GYVSGAAREE | LLAEFGSGTL | DLPALTRRLT | AIIEEAEEAP | 
    3700:
    GARPQLQDAW | RGPREPGPAG | RGDGDSGRSQ | REGQGEGETQ | EAAAAAAAAR | 
    3750:
    RQEQTLRDAT | MEVQRGQFQG | RPVSVWDVLF | SSYLSEARRD | ELLAQHAAGA | 
    3800:
    LGLPDLVAVL | TRVIEETEER | LSKVSFRGLR | RQVSASELHT | SGILGPETLR | 
    3850:
    DLAQGTKTLQ | EVTEMDSVKR | YLEGTSCIAG | VLVPAKDQPG | RQEKMSIYQA | 
    3900:
    MWKGVLRPGT | ALVLLEAQAA | TGFVIDPVRN | LRLSVEEAVA | AGVVGGEIQE | 
    3950:
    KLLSAERAVT | GYTDPYTGQQ | ISLFQAMQKD | LIVREHGIRL | LEAQIATGGV | 
    4000:
    IDPVHSHRVP | VDVAYRRGYF | DEEMNRVLAD | PSDDTKGFFD | PNTHENLTYV | 
    4050:
    QLLRRCVPDP | DTGLYMLQLA | GRGSAVHQLS | EELRCALRDA | RVTPGSGALQ | 
    4100:
    GQSVSVWELL | FYREVSEDRR | QDLLSRYRAS | TLTVEELGAT | LTSLLAQAQA | 
    4150:
    QARAEAEAGS | PRPDPREALR | AATMEVKVGR | LRGRAVPVWD | VLASGYVSRA | 
    4200:
    AREELLAEFG | SGTLDLPALT | RRLTAIIEEA | EEAPGARPQL | QDAWRGPREP | 
    4250:
    GPAGRGDGDS | GRSQREGQGE | GETQEAAAAT | AAARRQEQTL | RDATMEVQRG | 
    4300:
    QFQGRPVSVW | DVLFSSYLSE | ARRDELLAQH | AAGALGLPDL | VAVLTRVIEE | 
    4350:
    TEERLSKVSF | RGLRRQVSAS | ELHTSGILGP | ETLRDLAQGT | KTLQEVTEMD | 
    4400:
    SVKRYLEGTS | CIAGVLVPAK | DQPGRQEKMS | IYQAMWKGVL | RPGTALVLLE | 
    4450:
    AQAATGFVID | PVRNLRLSVE | EAVAAGVVGG | EIQEKLLSAE | RAVTGYTDPY | 
    4500:
    TGQQISLFQA | MQKDLIVREH | GIRLLEAQIA | TGGVIDPVHS | HRVPVDVAYR | 
    4550:
    RGYFDEEMNR | VLADPSDDTK | GFFDPNTHEN | LTYVQLLRRC | VPDPDTGLYM | 
    4600:
    LQLAGRGSAV | HQLSEELRCA | LRDARVTPGS | GALQGQSVSV | WELLFYREVS | 
    4650:
    EDRRQDLLSR | YRAGTLTVEE | LGATLTSLLA | QAQAQARAEA | EAGSPRPDPR | 
    4700:
    EALRAATMEV | KVGRLRGRAV | PVWDVLASGY | VSGAAREELL | AEFGSGTLDL | 
    4750:
    PALTRRLTAI | IEEAEEAPGA | RPQLQDAWRG | PREPGPAGRG | DGDSGRSQRE | 
    4800:
    GQGEGETQEA | AAAAAAARRQ | EQTLRDATME | VQRGQFQGRP | VSVWDVLFSS | 
    4850:
    YLSEARRDEL | LAQHAAGALG | LPDLVAVLTR | VIEETEERLS | KVSFRGLRRQ | 
    4900:
    VSASELHTSG | ILGPETLRDL | AQGTKTLQEV | TEMDSVKRYL | EGTSCIAGVL | 
    4950:
    VPAKDQPGRQ | EKMSIYQAMW | KGVLRPGTAL | VLLEAQAATG | FVIDPVRNLR | 
    5000:
    LSVEEAVAAG | VVGGEIQEKL | LSAERAVTGY | TDPYTGQQIS | LFQAMQKDLI | 
    5050:
    VREHGIRLLE | AQIATGGVID | PVHSHRVPVD | VAYRRGYFDE | EMNRVLADPS | 
    5090:
    DDTKGFFDPN | THENLTYLQL | LQRATLDPET | GLLFLSLSLQ | 
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    SMR:
    MIM:
    KEGG:
    Pfam:
    UniGene:
    Uniprot:
     
    FOR
    ELISA Kit for Human Epiplakin
    ELISA Kit for Human Epiplakin
    CLIA Kit for Human Epiplakin
    CLIA Kit for Human Epiplakin
    Polyclonal Antibody for Human Epiplakin
    Polyclonal Antibody for Human Epiplakin
    Monoclonal Antibody for Human Epiplakin
    Monoclonal Antibody for Human Epiplakin
    Protein for Human Epiplakin
    Protein for Human Epiplakin

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Epiplakin, a novel member of the plakin family originally identified as a 450-kDa human epidermal autoantigen: structure and tissue localization."
      Fujiwara S. , Takeo N. , Otani Y. , Parry D.A.D. , Kunimatsu M. , Lu R. , Sasaki M. , Matsuo N. , Khaleduzzaman M. , Yoshioka H.
      J. Biol. Chem.276:13340-13347(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA]
      tissue: Cervix carcinoma.
    2. 2.
      "Structure and heterogeneity of the human gene for epiplakin (EPPK1)."
      Takeo N. , Wang W. , Matsuo N. , Sumiyoshi H. , Yoshioka H. , Fujiwara S.
      J. Invest. Dermatol.121:1224-1226(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
    3. 3.
      "Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides."
      Gevaert K. , Goethals M. , Martens L. , Van Damme J. , Staes A. , Thomas G.R. , Vandekerckhove J.
      Nat. Biotechnol.21:566-569(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE OF 266-274
      tissue: Platelet.
    4. 4.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 4713-5090
      tissue: Testis.
    5. 5.
      "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."
      Olsen J.V. , Blagoev B. , Gnad F. , Macek B. , Kumar C. , Mortensen P. , Mann M.
      Cell127:635-648(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2508; SER-3042; SER-3576; SER-4110 AND SER-4644;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    6. 6.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2716; SER-3250; SER-3784; SER-4318 AND SER-4852;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    7. 7.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    8. 8.
      "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."
      Olsen J.V. , Vermeulen M. , Santamaria A. , Kumar C. , Miller M.L. , Jensen L.J. , Gnad F. , Cox J. , Jensen T.S. , Nigg E.A. , Brunak S. , Mann M.
      Sci. Signal.3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2422; SER-2508; SER-2716; SER-2956; SER-3042; SER-3250; SER-3490; SER-3576; SER-3784; SER-4024; SER-4110; SER-4318; SER-4558; SER-4644 AND SER-4852;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
      tissue: Cervix carcinoma.
    9. 9.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    10. 10.
      "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."
      Rigbolt K.T. , Prokhorova T.A. , Akimov V. , Henningsen J. , Johansen P.T. , Kratchmarova I. , Kassem M. , Mann M. , Olsen J.V. , Blagoev B.
      Sci. Signal.4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2716; SER-2718; SER-3250; SER-3252; SER-3784; SER-3786; SER-4318; SER-4320; SER-4852 AND SER-4854;IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Alpha Tumor necrosis Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2026 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter